BioCentury
ARTICLE | Distillery Therapeutics

Ophthalmic disease

December 19, 2017 8:54 PM UTC

Patient samples and mouse studies suggest inhibiting EPHX2 could help treat non-proliferative diabetic retinopathy (NPDR). In postmortem retinal tissue samples from patients, high levels of EPHX2 were...

BCIQ Company Profiles

Goethe University Frankfurt